Effect Of Phalatrikadi Churna Along With Dietery Modification And Musta Churna In The Patients Having Medodushti (Dyslipidemia)

Phase 2

• Conditions: Health Condition 1: E785- Hyperlipidemia, unspecified

• Registration Number: CTRI/2024/03/064569
• Lead Sponsor: All India Institute Of Ayurveda

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 April 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1)Patients Between The Age Group Of 21-60 Years Of Either Sex.

2)BMI Greater Than 25 Kg Per M2

3)Willing And Able To Participate In The Study For 1month.

4) Patients Having Abnormal Lipid Profile Eg T.Cholesterol Greater Than 200 And T.Cho/HDL Greater Than 4.5.

5)Patients With Strictly Controlled Diabetes Mellitus (Hba1c Less Than Or Equal To 6.5 Percent).

6)Patient With Pratyatma Lakshan Of Medodushti.

Exclusion Criteria

1)Patients With Poorly Controlled Diabetes Mellitus (Hba1c Greater Than 6.5Percent) And Hypertension (BP Greater Than 160 By 100 Mm Hg.

2)Pregnant Or Lactating Woman.

3)BMI Less Than 40kg Per M2

4)Patients With Genetic Syndromes, Severe Cardiovascular Disease Or Any Other Life-Threatening Condition.

5)History Of Hypersensitivity To Any Of The Trial Drugs Or Their Ingredients.

6)Patients Having Systemic Illness Which Will Interfere With The Course Of Procedure.

7)Patients Who Are Already Enrolled In Other Study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1)Significant Favourable Change In Level Of Dyslipidemia Index <br/ ><br>2)Improvement In The Signs And Symptoms Of Medoroga. <br/ ><br>Timepoint: Bsseline <br/ ><br>After 4Weeks <br/ ><br>After 8Weeks

Secondary Outcome Measures

Name	Time	Method
To Improve The Quality Of Life Sf 36Timepoint: Bsseline <br/ ><br>After 4Weeks <br/ ><br>After 8Weeks